Oncternal Therapeutics Inc. buy melinda
Start price
16.11.18
/
50%
€9.16
Target price
30.10.19
€18.94
Performance (%)
0.00%
End price
30.10.19
-
Summary
This prediction ended on 30.10.19 with a price of -. The BUY prediction by melinda closed unchanged from the start price. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Oncternal Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
According to melinda what are the pros and cons of Oncternal Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$
GTx, Inc. est une société biopharmaceutique spécialisée dans la découverte, le développement et la commercialisation de petites molécules pour le traitement du cancer, y compris des traitements du cancer du sein et de la prostate, ainsi que d’autres maladies graves.
Stopped prediction by melinda for Oncternal Therapeutics Inc.
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.15
08.11.20
08.11.20
€5.00
08.11.21
08.11.21
-29.28%
09.11.21
09.11.21
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.24
22.09.18
22.09.18
€22.10
16.11.18
16.11.18
-18.54%
16.11.18
16.11.18
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€30.12
25.06.17
25.06.17
€34.73
29.06.17
29.06.17
20.34%
29.06.17
29.06.17
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€21.91
12.06.17
12.06.17
€21.47
12.06.17
12.06.17
12.97%
12.06.17
12.06.17
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.29
12.06.17
12.06.17
€23.80
12.06.17
12.06.17
12.97%
12.06.17
12.06.17
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€27.91
14.04.17
14.04.17
€31.57
05.05.17
05.05.17
4.54%
05.05.17
05.05.17
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€140.70
17.11.10
17.11.10
€210.00
17.05.11
17.05.11
104.98%
17.05.11
17.05.11
Could be worthwhile Investment >10% per year